Skip to main content
Ian Sarembock, MD, Cardiology, Cincinnati, OH

IanJ.SarembockMDMB,ChB

Cardiology Cincinnati, OH

Adult Congenital Heart Disease, Interventional Cardiology, Cardiac Critical Care

Ohio Heart & Vascular Center

Dr. Sarembock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sarembock's full profile

Already have an account?

  • Office

    Retired
    Montgomery, OHIO
    Cincinnati, OH 45237
    Phone+1 513-206-1167

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Cardiovascular Disease, 1986 - 1988
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1975

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2007 - 2024
  • VA State Medical License
    VA State Medical License 1988 - 2008
  • TN State Medical License
    TN State Medical License 2002 - 2003
  • National Board of Physicians and Surgeons Cardiovascular Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Fellow (FACC) American College of Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Transcatheter Mitral-Valve Repair in Patients with Heart Failure  
    JoAnn Lindenfeld, Saibal Kar, Michael J Mack, Samir R Kapadia, Gregg W Stone, Ian J Sarembock, William T Abraham, Andreas Brieke, David J Cohen, Steven O Marx, Brian W..., The New England Journal of Medicine

Grant Support

  • Selectins Role In Vascular Injury In Gene-TargetedNational Heart, Lung, And Blood Institute2003–2004
  • Selectins Role In Vascular Injury In Gene-Targeted MiceNational Heart, Lung, And Blood Institute2001–2002
  • Novel Adenosine A2A Agonists In Vascular ProtectionNational Heart, Lung, And Blood Institute2000
  • Effect Of Thrombin Inhibition By Hirudin On AngioplastyNational Heart, Lung, And Blood Institute1991–1993

Professional Memberships